PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3476676

When is cloning lawful?

M Brumby·P Kasimba
View original source ↗Export metadata ↓

Abstract

The infertility (Medical Procedures) Act (Victoria) is the first legislation in the common-law world designed to regulate the practice of in vitro fertilization. This act explicitly prohibits "cloning," without providing a definition of this term. The legislative history of the act suggests that it refers only to the production of multiple, identical copies of human individuals. But other scientific procedures, for which cloning is also a correct scientific term, may unintentionally be banned. The act should be amended in order to remove doubts about the position of molecular biologists, cytologists, and cytogeneticists, whose work may involve the production of "clones" of human cells and/or human genes in vitro.

Explore related subjects

Advisory CommitteesAustraliaBiomedical ResearchClone CellsCloning, MolecularFertilization in VitroGenetic EngineeringGovernment RegulationHumansLegislation, MedicalRisk AssessmentGenetics and ReproductionInfertility (Medical Procedures) Act 1984 (VIC)Legal ApproachWaller CommitteeJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Brumby, P Kasimba. 1987. When is cloning lawful?. https://doi.org/10.1007/bf01533757

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗